DaVita Debt/Equity Ratio 2010-2025 | DVA

DaVita debt/equity ratio for the quarter ending March 31, 2025 was 0.

  • DaVita average debt/equity ratio for 2024 was 14.21, a 102.71% decline from 2023.
  • DaVita average debt/equity ratio for 2023 was 7.01, a 34.49% increase from 2022.
  • DaVita average debt/equity ratio for 2022 was 10.7, a 52.2% decline from 2021.

Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.

DaVita Debt/Equity Ratio 2010-2025 | DVA

  • DaVita average debt/equity ratio for 2024 was 14.21, a 102.71% decline from 2023.
  • DaVita average debt/equity ratio for 2023 was 7.01, a 34.49% increase from 2022.
  • DaVita average debt/equity ratio for 2022 was 10.7, a 52.2% decline from 2021.

Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.
Related Stocks
Company NameMarket
Cap
Quest Diagnostics (DGX)$18.3B
Encompass Health (EHC)$10.4B
Chemed (CHE)$8.5B
Option Care Health (OPCH)$5.3B
Elanco Animal Health (ELAN)$4.2B
RadNet (RDNT)$3.7B
Amedisys (AMED)$3B
LifeStance Health (LFST)$2.6B
Addus HomeCare (ADUS)$1.8B
Astrana Health (ASTH)$1.6B
U.S Physical Therapy (USPH)$1B
Pennant (PNTG)$907M
Aveanna Healthcare Holdings (AVAH)$886M
Atai Life Sciences (ATAI)$294M
Daxor (DXR)$36M
Ontrak (OTRK)$6M
MEDIROM Healthcare Technologies (MRM)$4M
Psychemedics (PMD)$0M